Medibio Archives | Be Korea-savvy
Medibio Broadens Opportunities with Compatibility to Fitbit Wearable Devices for Mental Health Measurement

Medibio Broadens Opportunities with Compatibility to Fitbit Wearable Devices for Mental Health Measurement

SYDNEY, Australia and MINNEAPOLIS, Jun. 13 (Korea Bizwire) — Medibio Limited  (ASX:MEB) (OTCQB:MDBIF), the world leader in objective measurement technology for mental health, has recently enhanced the compatibility of its mobile app product to accept data from Fitbit devices equipped with heart rate monitors. The mobile app, named Medibio Inform, allows businesses to offer employees [...]

Medibio Corporate Health Extends Global Footprint Signing Contract with Jacobs Engineering

Medibio Corporate Health Extends Global Footprint Signing Contract with Jacobs Engineering

SYDNEY, Australia and MINNEAPOLIS, May 25 (Korea Bizwire) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, today announced a significant contract for Medibio’s Corporate Health product with Dallas, TX-based Jacobs Engineering across their Asia Pacific, Middle East, and European divisions. Through the Mental Health Check-In, companies can offer employees [...]

Medibio Receives CE Certification

Medibio Receives CE Certification

SYDNEY, Australia and MINNEAPOLIS, May 2 (Korea Bizwire) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, is pleased to confirm it has received CE (Conformité Européenne) Marking certification for its first release technology product and platform. Demonstrating that the product complies with European health and safety standards, the CE [...]

Medibio Launches Global Corporate Mental Health Product

Medibio Launches Global Corporate Mental Health Product

SYDNEY, Australia and MINNEAPOLIS, Apr. 30 (Korea Bizwire) — Medibio Limited (MEB or the Company)(ASX:MEB)(OTCQB:MDBIF), a mental health technology company confirms the launch and release of the Company’s Corporate Mental Health for business product and platform (the Platform). The Platform allows businesses to offer employees the chance to ‘check-in on their mental health’ through a [...]

Medibio Announces Scientific Advisory Board

Medibio Announces Scientific Advisory Board

SYDNEY, Australia and MINNEAPOLIS, Apr. 25 (Korea Bizwire) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company confirms establishment of its Scientific Advisory Board (SAB). Scientific Advisory Board Charter/Purpose The Medibio Scientific Advisory Board is charged to advise the board of directors and executive leadership team on scientific matters involving [...]

Medibio Announces ISO 13485 Certification

Medibio Announces ISO 13485 Certification

SYDNEY, Australia and MINNEAPOLIS, Jan. 10 (Korea Bizwire) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF) has received a Certificate of Compliance certifying that the Company’s Quality Management System complies with the requirements of ISO 13485.  This also includes conformance with the Canadian Medical Device Conformity Assessment System (CMDCAS).  The certification was issued by [...]

Mayo Clinic to Begin Prospective Clinical Study with Medibio Technology for Expanded Market Opportunities

Mayo Clinic to Begin Prospective Clinical Study with Medibio Technology for Expanded Market Opportunities

SYDNEY, Australia and MINNEAPOLIS, Dec. 14 (Korea Bizwire) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company that has pioneered the use of objective biometrics to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions,  is pleased to announce the first prospective clinical trial [...]

Medibio Completes Heavily Oversubscribed Institutional Placement for $13.9 million to Accelerate Commercialisation

Medibio Completes Heavily Oversubscribed Institutional Placement for $13.9 million to Accelerate Commercialisation

SYDNEY, Australia and MINNEAPOLIS, Oct. 12 (Korea Bizwire) — Medibio Limited (ASX:MEB)(OTCQB:MDBIF) is pleased to announce that it has received firm commitments to raise $13.9 million via the placement of 38,736,640 ordinary shares at a price of $0.36 per share.  The placement will be conducted in a single tranche using the Company’s existing placement capacity [...]

Medibio Enters Into an Agreement with Otsuka Pharmaceutical Development & Commercialization, Inc.

Medibio Enters Into an Agreement with Otsuka Pharmaceutical Development & Commercialization, Inc.

SYDNEY, Australia and MINNEAPOLIS, Oct. 8 (Korea Bizwire) —  Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), is a mental health technology company that has pioneered the use of objective biometrics to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions,  is pleased to announce it has entered into [...]

Medibio Building Credentials to “Scale” via Appointment of Healthcare & Telehealth Icon to Board of Directors

Medibio Building Credentials to “Scale” via Appointment of Healthcare & Telehealth Icon to Board of Directors

SYDNEY, Australia and MINNEAPOLIS, Jul. 19 (Korea Bizwire) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a digital health company that has developed an objective testing system to assist in the screening, diagnosis and treatment effectiveness of depression, chronic stress and other mental health disorders, is pleased to announce the appointment of Dr Adam [...]